We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




New Test Measures Biological Age Using Saliva or Blood

By LabMedica International staff writers
Posted on 26 Feb 2025
Print article
Image: The test can effectively estimate biological age and works well using saliva samples (Photo courtesy of 123RF)
Image: The test can effectively estimate biological age and works well using saliva samples (Photo courtesy of 123RF)

Biological age refers to the rate at which a person’s body is aging, and it may differ from their chronological age. Factors such as genetics, lifestyle, and health conditions influence biological age. Gaining a better understanding of biological aging can help researchers and clinicians detect age-related diseases, such as Alzheimer’s disease, and create treatments to slow the aging process. However, many current methods for measuring biological age are costly and complex. Now, a new model addresses these issues with a simple yet effective approach.

A research team comprising of experts from both industry including EpiMedTech Global (Hong Kong) and academic institutions including Oxford University (Oxford, UK) has developed EpiAgePublic, a method to estimate biological age by analyzing only three key DNA sites in the ELOVL2 gene, which is a well-known aging marker. Unlike traditional methods that require the analysis of thousands of DNA regions, this approach streamlines the process without sacrificing accuracy. The study examined data from over 4,600 individuals with varying health conditions, including Alzheimer’s disease and HIV, and found that EpiAgePublic accurately tracks aging patterns and identifies factors such as chronic illness or stress that speed up the aging process. The findings, published in Aging, show that EpiAgePublic is at least as effective, if not more so, than more complex models in predicting biological age across diverse populations.

The researchers also showed that the test works well with saliva samples, providing a convenient and non-invasive alternative to blood-based tests. This makes epigenetic age testing easier to perform in both clinical and research settings. The ability to measure epigenetic aging with a quick and cost-effective test could have significant implications for healthcare, longevity research, and personalized medicine. The method could be used in hospitals, wellness clinics, and studies focused on aging to monitor the aging process and evaluate anti-aging treatments. Additionally, it may help clinicians detect early signs of aging-related diseases, leading to better preventive care. The study’s findings also underscore the potential of next-generation sequencing in epigenetic research, which could pave the way for more precise and accessible diagnostics for aging. Future research will aim to expand this model to other health conditions and integrate it into routine medical practice.

“The simplicity and precision of epiAgePublic, designed for compatibility with next-generation sequencing (NGS) technologies, mark a significant step forward in the field of epigenetic research,” noted the researchers.

Related Links:
EpiMedTech Global
Oxford University

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
New
Typhoid Rapid Test
OnSite Typhoid IgG/IgM Combo Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.